Insiders who reported open-market trades in the last 12 months at the companies Simeon George files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Simeon George is a corporate insider, tracked as Director, 10% Owner of ADARx Pharmaceuticals, Inc. (ADRX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Simeon George submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Simeon George been buying or selling stock?
Recorded transactions: 6 open-market purchases ($78.70M) and 0 open-market sales across all tracked filings.
Simeon George is Director, 10% Owner of ADARx Pharmaceuticals, Inc. (ADRX). 5 SEC Form 4 filings on record going back to 2025, most recently on 30 September 2026. Most recent open-market trade: bought $10.07M of ADRX on 30 September 2026. Lifetime open-market purchases: $78.70M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Simeon George.
InsiderAlpha's records for Simeon George go back to 2025: 5 primary Form 4 filings, an average of 2.5 per year. The typical open-market purchase is $13.12M (6 buys totaling $78.70M). The largest single buy on record is $50.00M of CRSP in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
